BC-40-TU13_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, N-(4-(4-Methyl-1-piperazinyl)phenyl)-9-acridinamine, alpha2C-Adrenoceptor Antagonists;ADRA2C antagonist targeting ADRA2C (Novartis, 540335)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/540335
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the BC-40-TU13_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPL37A ribosomal protein L37a 0.47526
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.47526
RPL41 ribosomal protein L41 0.270516
C19ORF33 chromosome 19 open reading frame 33 0.269655
ELOB elongin B 0.256152
COX8A cytochrome c oxidase subunit VIIIA (ubiquitous) 0.245831
RPL38 ribosomal protein L38 0.240486
COX6B1 cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) 0.201357

decreased expression

Symbol Name Standardized Value
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha -0.47526
SPG21 spastic paraplegia 21 (autosomal recessive, Mast syndrome) -0.257023
SCPEP1 serine carboxypeptidase 1 -0.223088
ARF6 ADP-ribosylation factor 6 -0.201357